Surgery Partners, Inc.
SGRY· Nasdaq
SGRYSurgery Partners, Inc.
Filed Mar 10, 2021 · 10-K · 69 days after period end · 0001638833-21-000034
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $548.30M | $517.20M | $491.20M | $460.35M |
| Net Income | $5.50M | -$19.20M | -$147.70M | -$32.18M |
| EPS Diluted | — | -$0.59 | -$3.25 | -$0.83 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 10, 2021 · 69 d after period end
